정윤숙

진료분야

대장암, 대장폴립 및 대장질환, 염증성장질환, 치료내시경, 헬리코박터, 역류성 식도염

진료일정

  • 외래진료
  • 국내 학회
  • 국외 학회
  • 강의
  • 휴가
  • 기타
구분
오전
오후

학력 및 경력

[학력]
1999 - 2005   연세대학교 의과대학 졸업
2007 - 2010   연세대학교 대학원 의학석사 
2010 - 2015   연세대학교 대학원 의학박사


[경력]
2005 - 2006   연세대학교 세브란스 병원 인턴 
2006 - 2010   연세대학교 세브란스 병원 내과 전공의 
2010 - 2011   연세대학교 세브란스 병원 소화기내과 임상강사  
2011 - 2012   연세대학교 세브란스 병원 소화기내과 임상연구조교수
2012 - 2015   강북삼성병원 소화기내과 임상조교수
2015 - 2019    강북삼성병원 소화기내과 조교수
2019 - 현재    강북삼성병원 소화기내과 부교수

학회 활동

[학회활동]
대한 장연구학회 편집위원
대한 소화기내시경학회 정회원
대한소화기학회 정회원
대한내과학회 정회원
대한소화기기능성질환?운동학회 정회원



[수상경력]
2009 연세대학교 의과대학 내과학 교실 연구비 수상
2010 연세대학교 대학원 의학석사 우수 논문상 
2010 한일 IBD 심포지엄 best poster presentation
2012 연세대학교 의과대학 소화기내과 우수 업적상
2017 성균관대학교 의과대학 연구업적 우수 교원 
2018 성균관대학교 의과대학 교육영역 우수 교수
2021 SKKU-Fellowship 교수 선정  

대표 논문

[국외]
1. Jung YS, Park DI, Kim ER et al. Quantifying Exposure to Diagnostic Radiation and Factors Associated with Exposure to High Levels of Radiation in Korean Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2013 Aug;19(9):1852-1857

2.Jung YS, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Sohn JH, Park DI. Complete biopsy resection of diminutive polyps. Endoscopy. 2013 Dec;45(12):1024-9

3. Jung YS, Cheon JH, Park SJ, Hong SP, Kim TI, Kim WH. Long-term clinical outcomes of Crohn's disease and intestinal Behcet's disease. Inflamm Bowel Dis. 2013 Jan;19(1):99-105

4. Jung YS, Cheon JH, Park SJ, Hong SP, Kim TI, Kim WH Clinical Course of Intestinal Behcet's Disease During the First Five Years. Dig Dis Sci. 2013 Feb;58(2):496-503

5. Jung YS, Yoon JY, Hong SP, Kim TI, Kim WH, Cheon JH. Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet's disease. Inflamm Bowel Dis. 2012 Jun;18(6):1064-71

6. Jung YS, Cheon JH, Hong SP, Kim TI, Kim WH. Clinical outcomes and prognostic factors for thiopurine maintenance therapy in patients with intestinal Behcet's disease. Inflamm Bowel Dis. 2012 Apr;18(4):750-7

7. Jung YS, Kim SW, Yoon JY, Lee JH, Jeon SM, Hong SP, Kim TI, Kim WH, Cheon JH. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease. Inflamm Bowel Dis. 2011 Oct;17(10):2130-7.

8. Jung YS, Yoon JY, Lee JH, Jeon SM, Hong SP, Kim TI, Kim WH, Cheon JH. Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet's disease. Inflamm Bowel Dis. 2011 Jul;17(7):1594-602

9. Jung YS, Park JJ, Kim SW, Hong SP, Kim TI, Kim WH, Cheon JH. Correlation between Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) Expression and Endoscopic Activity in Inflammatory Bowel Diseases. Dig Liver Dis. 2012 Nov;44(11):897-903

10. Jung YS, Hong SP, Kim TI, Kim WH, Cheon JH. Early Versus Late Surgery in Patients with Intestinal Behcet's Disease. Dis Colon Rectum. 2012 Jan;55(1):65-71.

11. Jung YS, Hong SP, Kim TI, Kim WH, Cheon JH. Long-Term Clinical Outcomes and Factors Predictive of Relapse After 5-Aminosalicylate or Sulfasalazine Therapy in Patients With Intestinal Behcet Disease. J Clin Gastroenterol. 2012 May;46(5):e38-45

12. Jung YS, Cheon JH, Park JJ, Moon CM, Kim ES, Lee JH, Kim SW, Kim JH, Hong SP, Kim TI, Kim WH. Correlation of genotypes for thiopurine methyltransferase and inosine triphosphate pyrophosphatase with long-term clinical outcomes in Korean patients with inflammatory bowel diseases during treatment with thiopurine drugs. J Hum Genet. 2010 Feb;55(2):121-3

13. Jung YS, Song CS, Kim ER et al. Seasonal Variation in Months of Births and Symptom Flares in Korean Patients with Inflammatory Bowel Disease. Gut Liver. 2013 Nov;7(6):661-7

14. Jung YS, Seok HS, Park DI et al. Clear Liquid Diet is Not Mandatory for Polyethylene Glycol-based Bowel Preparation for Afternoon Colonoscopy in Healthy Outpatients. Gut Liver. 2013 Nov;7(6):681-7

15. Jung YS, Park JH, Kim HJ et al. Insufficient Knowledge of Korean Gastroenterologist Regarding Vaccinating Patients with Inflammatory Bowel Disease. Gut Liver. 2013. In press

16. Jung YS, Moon CM, Park DI et al. Radiation Exposure from abdominal imaging studies in Patients with Intestinal Behcet’s Disease . Gut Liver. 2013. In press

17. Jung YS, Park DI. Submucosal injection solutions for endoscopic mucosal resection and endoscopic submucosal dissection of gastrointestinal neoplasms. Gastrointest Interv 2013; 2:73?77

18. Comparison of Efficacy of Prophylactic Endoscopic Therapies for Postpolypectomy Bleeding in the Colorectum: A Systematic Review and Network Meta-Analysis. Am J Gastroenterol. 2016;111:1230-43. (corresponding author)

19. Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study. J Crohns Colitis 2017;11:954-62. (first author)

20. Colorectal cancer screening with the fecal immunochemical test in persons aged 30 to 49 years: focusing on the age for commencing screening. Gastrointest Endosc 2017;86:892-9. (first author)

21. Risk of developing metachronous advanced colorectal neoplasia after colonoscopic polypectomy in patients aged 30 to 39 and 40 to 49 years. Gastrointest Endosc 2018;88:715-23. (corresponding author)

22. Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer. Gastrointest Endosc 2018;88:128-35. (corresponding author)

23. Yield of repeat colonoscopy in asymptomatic individuals with a positive fecal immunochemical test and recent colonoscopy. Gastrointest Endosc 2019;89:1037-43. (corresponding author)

24. Usefulness of risk stratification models for colorectal cancer based on fecal hemoglobin concentration and clinical risk factors. Gastrointest Endosc 2019;89:1204-11. (corresponding author)

25. Risk of developing metachronous advanced colorectal neoplasia after resection of low-risk diminutive versus small adenomas. Gastrointest Endosc 2020;91:622-30. (corresponding author)

26. A comparative systematic review and meta-analysis of 1 to 5 mm versus 6 to 9 mm adenomas on the risk of metachronous advanced colorectal neoplasia. Gastrointest Endosc. 2020;92:692-701. (first author)

27. Prevalence of and Risk Factors for Colorectal Neoplasia in Asymptomatic Young Adults (20-39 Years Old). Clin Gastroenterol Hepatol 2019;17:115-22. (corresponding author

28. Effect of Cotinine-Verified Change in Smoking Status on Risk of Metachronous Colorectal Neoplasia After Polypectomy. Clin Gastroenterol Hepatol 2020;18:163-70. (first author & corresponding author)

29. Serrated Polyps and the Risk of Metachronous Colorectal Advanced Neoplasia: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2022;20:31-43. (first author)

30. Risk of Developing Metachronous Advanced Colorectal Neoplasia After Polypectomy in Patients With Multiple Diminutive or Small Adenomas. Am J Gastroenterol 2019;114:1657-64. (corresponding author)

31. Association Between Family History of Gastric Cancer and the Risk of Gastric Cancer and Adenoma: A Nationwide Population-Based Study. Am J Gastroenterol. 2022;117:1255-1263 (first author)

기타

  • 정보보호관리체계(ISMS) 인증
  • 국제정보보호(ISO27001) 인증
  • 보건복지부
    의료기관 인증병원
  • 생명의학연구윤리 국제인증 획득
  • 美, 하원 표창장
  • 美, 존스홉킨스
    연구협약 체결